ID   LIPE_HUMAN              Reviewed;         500 AA.
AC   Q9Y5X9; B0LPG6; Q6P9C8; Q6UW82;
DT   26-JUL-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   10-MAY-2017, entry version 156.
DE   RecName: Full=Endothelial lipase;
DE            EC=3.1.1.3;
DE   AltName: Full=Endothelial cell-derived lipase;
DE            Short=EDL;
DE            Short=EL;
DE   Flags: Precursor;
GN   Name=LIPG; ORFNames=UNQ387/PRO719;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Endothelial cell;
RX   PubMed=10318835; DOI=10.1074/jbc.274.20.14170;
RA   Hirata K., Dichek H.L., Cioffi J.A., Choi S.Y., Leeper N.J.,
RA   Quintana L., Kronmal G.S., Cooper A.D., Quertermous T.;
RT   "Cloning of a unique lipase from endothelial cells extends the lipase
RT   gene family.";
RL   J. Biol. Chem. 274:14170-14175(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=10192396; DOI=10.1038/7766;
RA   Jaye M., Lynch K.J., Krawiec J., Marchadier D., Maugeais C., Doan K.,
RA   South V., Amin D., Perrone M., Rader D.J.;
RT   "A novel endothelial-derived lipase that modulates HDL metabolism.";
RL   Nat. Genet. 21:424-428(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   CHARACTERIZATION.
RX   PubMed=12032167;
RA   McCoy M.G., Sun G.-S., Marchadier D., Maugeais C., Glick J.M.,
RA   Rader D.J.;
RT   "Characterization of the lipolytic activity of endothelial lipase.";
RL   J. Lipid Res. 43:921-929(2002).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-393.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [9]
RP   SUBUNIT.
RX   PubMed=19567873; DOI=10.1074/jbc.M109.037002;
RA   Griffon N., Jin W., Petty T.J., Millar J., Badellino K.O., Saven J.G.,
RA   Marchadier D.H., Kempner E.S., Billheimer J., Glick J.M., Rader D.J.;
RT   "Identification of the active form of endothelial lipase, a homodimer
RT   in a head-to-tail conformation.";
RL   J. Biol. Chem. 284:23322-23330(2009).
RN   [10]
RP   VARIANTS SER-96; ILE-111 AND HIS-312.
RX   PubMed=12966036; DOI=10.1093/hmg/ddg314;
RA   Morabia A., Cayanis E., Costanza M.C., Ross B.M., Flaherty M.S.,
RA   Alvin G.B., Das K., Gilliam T.C.;
RT   "Association of extreme blood lipid profile phenotypic variation with
RT   11 reverse cholesterol transport genes and 10 non-genetic
RT   cardiovascular disease risk factors.";
RL   Hum. Mol. Genet. 12:2733-2743(2003).
CC   -!- FUNCTION: Has phospholipase and triglyceride lipase activities.
CC       Hydrolyzes high density lipoproteins (HDL) more efficiently than
CC       other lipoproteins. Binds heparin.
CC   -!- CATALYTIC ACTIVITY: Triacylglycerol + H(2)O = diacylglycerol + a
CC       carboxylate.
CC   -!- ENZYME REGULATION: Inhibited by serum.
CC   -!- SUBUNIT: Head to tail homodimer. {ECO:0000269|PubMed:19567873}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y5X9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y5X9-2; Sequence=VSP_013302, VSP_013303;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: High level of expression in the liver,
CC       placenta, lung, thyroid, kidney, testis and in the corpus luteum
CC       of the ovary. Expressed also in coronary artery endothelial cells,
CC       umbilical vein endothelial cells and in hepatocytes and
CC       osteosarcoma cell lines. Not detected in heart, brain and muscle.
CC   -!- MISCELLANEOUS: It is termed endothelial lipase due to the fact
CC       that it is synthesized in endothelial cells, a characteristic that
CC       distinguishes it from other members of the family. However, this
CC       protein is also expressed in other cell types.
CC   -!- SIMILARITY: Belongs to the AB hydrolase superfamily. Lipase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF118767; AAD30434.1; -; mRNA.
DR   EMBL; AY358928; AAQ89287.1; -; mRNA.
DR   EMBL; EU332856; ABY87545.1; -; Genomic_DNA.
DR   EMBL; CH471096; EAW62947.1; -; Genomic_DNA.
DR   EMBL; BC060825; AAH60825.1; -; mRNA.
DR   CCDS; CCDS11938.1; -. [Q9Y5X9-1]
DR   RefSeq; NP_001294935.1; NM_001308006.1.
DR   RefSeq; NP_006024.1; NM_006033.3. [Q9Y5X9-1]
DR   UniGene; Hs.465102; -.
DR   ProteinModelPortal; Q9Y5X9; -.
DR   SMR; Q9Y5X9; -.
DR   BioGrid; 114788; 23.
DR   IntAct; Q9Y5X9; 2.
DR   STRING; 9606.ENSP00000261292; -.
DR   BindingDB; Q9Y5X9; -.
DR   ChEMBL; CHEMBL5080; -.
DR   GuidetoPHARMACOLOGY; 2591; -.
DR   SwissLipids; SLP:000000567; -.
DR   ESTHER; human-LIPG; Lipoprotein_Lipase.
DR   iPTMnet; Q9Y5X9; -.
DR   PhosphoSitePlus; Q9Y5X9; -.
DR   BioMuta; LIPG; -.
DR   DMDM; 22001808; -.
DR   PaxDb; Q9Y5X9; -.
DR   PeptideAtlas; Q9Y5X9; -.
DR   PRIDE; Q9Y5X9; -.
DR   DNASU; 9388; -.
DR   Ensembl; ENST00000261292; ENSP00000261292; ENSG00000101670. [Q9Y5X9-1]
DR   Ensembl; ENST00000580036; ENSP00000462420; ENSG00000101670. [Q9Y5X9-2]
DR   GeneID; 9388; -.
DR   KEGG; hsa:9388; -.
DR   UCSC; uc002ldu.2; human. [Q9Y5X9-1]
DR   CTD; 9388; -.
DR   DisGeNET; 9388; -.
DR   GeneCards; LIPG; -.
DR   HGNC; HGNC:6623; LIPG.
DR   HPA; HPA016966; -.
DR   MIM; 603684; gene.
DR   neXtProt; NX_Q9Y5X9; -.
DR   OpenTargets; ENSG00000101670; -.
DR   PharmGKB; PA30395; -.
DR   eggNOG; ENOG410IJUA; Eukaryota.
DR   eggNOG; ENOG4111GMM; LUCA.
DR   GeneTree; ENSGT00760000119069; -.
DR   HOGENOM; HOG000038553; -.
DR   HOVERGEN; HBG002259; -.
DR   InParanoid; Q9Y5X9; -.
DR   KO; K01046; -.
DR   OMA; QSWYNLW; -.
DR   OrthoDB; EOG091G052B; -.
DR   PhylomeDB; Q9Y5X9; -.
DR   TreeFam; TF324997; -.
DR   Reactome; R-HSA-192456; Digestion of dietary lipid.
DR   ChiTaRS; LIPG; human.
DR   GenomeRNAi; 9388; -.
DR   PMAP-CutDB; Q9Y5X9; -.
DR   PRO; PR:Q9Y5X9; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000101670; -.
DR   CleanEx; HS_LIPG; -.
DR   ExpressionAtlas; Q9Y5X9; baseline and differential.
DR   Genevisible; Q9Y5X9; HS.
DR   GO; GO:0009986; C:cell surface; IDA:MGI.
DR   GO; GO:0005769; C:early endosome; IDA:MGI.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:MGI.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004465; F:lipoprotein lipase activity; TAS:Reactome.
DR   GO; GO:0008970; F:phosphatidylcholine 1-acylhydrolase activity; IDA:MGI.
DR   GO; GO:0004620; F:phospholipase activity; IDA:BHF-UCL.
DR   GO; GO:0008283; P:cell proliferation; IEA:Ensembl.
DR   GO; GO:0042632; P:cholesterol homeostasis; IMP:BHF-UCL.
DR   GO; GO:0034375; P:high-density lipoprotein particle remodeling; IMP:BHF-UCL.
DR   GO; GO:0044241; P:lipid digestion; TAS:Reactome.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0009395; P:phospholipid catabolic process; NAS:BHF-UCL.
DR   GO; GO:0055091; P:phospholipid homeostasis; IMP:BHF-UCL.
DR   GO; GO:0032376; P:positive regulation of cholesterol transport; IDA:BHF-UCL.
DR   GO; GO:0010983; P:positive regulation of high-density lipoprotein particle clearance; IMP:BHF-UCL.
DR   GO; GO:0050746; P:regulation of lipoprotein metabolic process; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0043691; P:reverse cholesterol transport; IMP:BHF-UCL.
DR   CDD; cd00707; Pancreat_lipase_like; 1.
DR   Gene3D; 2.60.60.20; -; 1.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR013818; Lipase/vitellogenin.
DR   InterPro; IPR016272; Lipase_LIPH.
DR   InterPro; IPR033906; Lipase_N.
DR   InterPro; IPR002330; Lipo_Lipase.
DR   InterPro; IPR001024; PLAT/LH2_dom.
DR   InterPro; IPR000734; TAG_lipase.
DR   PANTHER; PTHR11610; PTHR11610; 1.
DR   Pfam; PF00151; Lipase; 1.
DR   Pfam; PF01477; PLAT; 1.
DR   PIRSF; PIRSF000865; Lipoprotein_lipase_LIPH; 1.
DR   PRINTS; PR00822; LIPOLIPASE.
DR   PRINTS; PR00821; TAGLIPASE.
DR   SMART; SM00308; LH2; 1.
DR   SUPFAM; SSF49723; SSF49723; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   PROSITE; PS00120; LIPASE_SER; 1.
DR   PROSITE; PS50095; PLAT; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disulfide bond; Glycoprotein;
KW   Heparin-binding; Hydrolase; Lipid degradation; Lipid metabolism;
KW   Polymorphism; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21    500       Endothelial lipase.
FT                                /FTId=PRO_0000017797.
FT   DOMAIN      347    482       PLAT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00152}.
FT   REGION      325    337       Heparin-binding. {ECO:0000250}.
FT   COMPBIAS    118    121       Poly-Val.
FT   ACT_SITE    169    169       Nucleophile. {ECO:0000250}.
FT   ACT_SITE    193    193       Charge relay system.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10037}.
FT   ACT_SITE    274    274       Charge relay system.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10037}.
FT   CARBOHYD     80     80       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    136    136       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    393    393       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    469    469       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    491    491       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     64     77       {ECO:0000255|PROSITE-ProRule:PRU00152}.
FT   DISULFID    252    272       {ECO:0000255|PROSITE-ProRule:PRU00152}.
FT   DISULFID    297    316       {ECO:0000255|PROSITE-ProRule:PRU00152}.
FT   DISULFID    308    311       {ECO:0000255|PROSITE-ProRule:PRU00152}.
FT   DISULFID    463    483       {ECO:0000255|PROSITE-ProRule:PRU00152}.
FT   VAR_SEQ     346    354       VYHYQMKIH -> GNLQSLECP (in isoform 2).
FT                                {ECO:0000303|PubMed:12975309}.
FT                                /FTId=VSP_013302.
FT   VAR_SEQ     355    500       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12975309}.
FT                                /FTId=VSP_013303.
FT   VARIANT      26     26       G -> S (in dbSNP:rs9963243).
FT                                /FTId=VAR_034082.
FT   VARIANT      96     96       G -> S (in dbSNP:rs150879681).
FT                                {ECO:0000269|PubMed:12966036}.
FT                                /FTId=VAR_017027.
FT   VARIANT     111    111       T -> I (in dbSNP:rs2000813).
FT                                {ECO:0000269|PubMed:12966036}.
FT                                /FTId=VAR_017028.
FT   VARIANT     312    312       R -> H. {ECO:0000269|PubMed:12966036}.
FT                                /FTId=VAR_017029.
FT   CONFLICT    476    476       R -> Q (in Ref. 6; AAH60825).
FT                                {ECO:0000305}.
SQ   SEQUENCE   500 AA;  56795 MW;  96EC95125CD2A3FD CRC64;
     MSNSVPLLCF WSLCYCFAAG SPVPFGPEGR LEDKLHKPKA TQTEVKPSVR FNLRTSKDPE
     HEGCYLSVGH SQPLEDCSFN MTAKTFFIIH GWTMSGIFEN WLHKLVSALH TREKDANVVV
     VDWLPLAHQL YTDAVNNTRV VGHSIARMLD WLQEKDDFSL GNVHLIGYSL GAHVAGYAGN
     FVKGTVGRIT GLDPAGPMFE GADIHKRLSP DDADFVDVLH TYTRSFGLSI GIQMPVGHID
     IYPNGGDFQP GCGLNDVLGS IAYGTITEVV KCEHERAVHL FVDSLVNQDK PSFAFQCTDS
     NRFKKGICLS CRKNRCNSIG YNAKKMRNKR NSKMYLKTRA GMPFRVYHYQ MKIHVFSYKN
     MGEIEPTFYV TLYGTNADSQ TLPLEIVERI EQNATNTFLV YTEEDLGDLL KIQLTWEGAS
     QSWYNLWKEF RSYLSQPRNP GRELNIRRIR VKSGETQRKL TFCTEDPENT SISPGRELWF
     RKCRDGWRMK NETSPTVELP
//
